The IMACTIS CT-Navigation system provides stereotactic needle guidance, allowing for pre-planning and continuous control during minimally invasive procedures. It’s received FDA 510k clearance, and the system is approved under the European Union’s Medical Devices Regulation.
Though the technology is currently focused on CT images, GE plans to expand the system with its larger image-guided therapy business.
Financial details for the transaction weren’t disclosed, but GE HealthCare said it plans to fund the acquisition with cash on hand.
The agreement marks the newly independent company’s first acquisition.
GE completed the spin-off from GE Healthcare on Jan. 4.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
